Dare Bioscience, Inc. — Director's Dealing 2015

Dec 3, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Cerulean Pharma Inc. (CERU)
CIK: 0001401914
Period of Report: 2015-12-01

Reporting Person: Carvajal Alejandra (VP, General Counsel)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2015-12-01	Incentive Stock Option (right to buy)	$3.29	A	158000	Acquired	2024-11-30	Common Stock (158000)	Direct

Footnotes

F1: The shares underlying this option vest in three equal installments on December 1, 2016, December 1, 2017 and December 1, 2018, respectively, subject to Ms. Carvajal's continued service.